News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,928 Results
Type
Article (40925)
Company Profile (267)
Press Release (680726)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204682)
Career Advice (2024)
Deals (35534)
Drug Delivery (110)
Drug Development (81396)
Employer Resources (173)
FDA (16417)
Job Trends (14947)
News (346423)
Policy (32731)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2568)
Accelerated approval (33)
Adcomms (24)
Allergies (142)
Alliances (49583)
ALS (169)
Alzheimer's disease (1671)
Antibody-drug conjugate (ADC) (312)
Approvals (16687)
Artificial intelligence (514)
Autoimmune disease (159)
Automation (39)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (190)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (640)
Cancer (4814)
Cardiovascular disease (399)
Career advice (1709)
Career pathing (36)
CAR-T (282)
CDC (44)
Celiac Disease (2)
Cell therapy (744)
Cervical cancer (36)
Clinical research (69593)
Collaboration (1704)
Company closure (4)
Compensation (1163)
Complete response letters (56)
COVID-19 (2713)
CRISPR (91)
C-suite (850)
Cystic fibrosis (143)
Data (6247)
Decentralized trials (2)
Denatured (25)
Depression (134)
Diabetes (502)
Diagnostics (6694)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (253)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (232)
Earnings (90198)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117312)
Executive appointments (977)
FDA (19544)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1471)
Gene editing (197)
Generative AI (43)
Gene therapy (596)
GLP-1 (966)
Government (4659)
Grass and pollen (6)
Guidances (383)
Healthcare (18875)
HIV (60)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (252)
Immuno-oncology (57)
Indications (112)
Infectious disease (2983)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (252)
Interviews (315)
IPO (16642)
IRA (50)
Job creations (3644)
Job search strategy (1429)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (547)
Leadership (31)
Legal (7953)
Liver cancer (91)
Longevity (14)
Lung cancer (650)
Lymphoma (377)
Machine learning (42)
Management (59)
Manufacturing (797)
MASH (164)
Medical device (13774)
Medtech (13828)
Mergers & acquisitions (19965)
Metabolic disorders (1270)
Multiple sclerosis (163)
NASH (16)
Neurodegenerative disease (316)
Neuropsychiatric disorders (88)
Neuroscience (2904)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4515)
Now hiring (67)
Obesity (596)
Opinion (259)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (227)
Parkinson's disease (280)
Partnered (33)
Patents (499)
Patient recruitment (491)
Peanut (56)
People (58880)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21690)
Phase 2 (30627)
Phase 3 (22820)
Pipeline (5336)
Policy (282)
Postmarket research (2564)
Preclinical (9201)
Press Release (64)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (281)
Rare diseases (837)
Real estate (5955)
Recruiting (70)
Regulatory (24503)
Reports (53)
Research institute (2389)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (148)
Series A (238)
Series B (191)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3615)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1006)
Venture capital (88)
Weight loss (381)
Women's health (92)
Worklife (18)
Date
Today (126)
Last 7 days (548)
Last 30 days (2155)
Last 365 days (29852)
2026 (3589)
2025 (30175)
2024 (35218)
2023 (40079)
2022 (51185)
2021 (55713)
2020 (54083)
2019 (46544)
2018 (35019)
2017 (32114)
2016 (31486)
2015 (37556)
2014 (31320)
2013 (26348)
2012 (28575)
2011 (29264)
2010 (27332)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39236)
Australia (6413)
California (11313)
Canada (3294)
China (1100)
Colorado (479)
Connecticut (479)
Delaware (338)
Europe (84557)
Florida (1694)
Georgia (358)
Hawaii (3)
Idaho (61)
Illinois (862)
India (66)
Indiana (522)
Iowa (22)
Japan (432)
Kansas (127)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1382)
Massachusetts (8097)
Michigan (326)
Minnesota (629)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3009)
New Mexico (28)
New York (2982)
North Carolina (1455)
North Dakota (8)
Northern California (5532)
Ohio (334)
Oklahoma (21)
Oregon (41)
Pennsylvania (2283)
Puerto Rico (24)
Rhode Island (48)
South America (1108)
South Carolina (66)
South Dakota (1)
Southern California (4401)
Tennessee (174)
Texas (1745)
United States (40100)
Utah (336)
Vermont (1)
Virginia (262)
Washington D.C. (81)
Washington State (921)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
721,928 Results for "apollo endosurgery inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apollo Neuroscience Announces 2025 Year in Review
February 2, 2026
·
6 min read
Press Releases
Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026
December 29, 2025
·
5 min read
Deals
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Apollo Endosurgery, Inc. (Nasdaq: APEN) for a cash price of $10 per share, reflecting an enterprise value of approximately $615 million.
November 29, 2022
·
8 min read
Press Releases
neurocare group’s Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression
September 11, 2025
·
3 min read
Business
Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022
Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced financial results for the third quarter ended September 30, 2022 and recent corporate highlights.
November 1, 2022
·
14 min read
Press Releases
Marker Therapeutics Provides Update on Phase 1 APOLLO Study Highlighting Encouraging Overall Response Rates in Relapsed Lymphoma
August 26, 2025
·
9 min read
Lone Star Bio
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity
Apollo Endosurgery, Inc. announced today that the MERIT trial, published in The Lancet earlier this year (1), was selected as 2022 Top Story in Gastroenterology.
December 13, 2022
·
6 min read
Business
Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022
Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced financial results for the second quarter ended June 30, 2022 and recent corporate highlights.
August 2, 2022
·
13 min read
Business
Apollo Endosurgery to Report Third Quarter Results on November 1, 2022
Apollo Endosurgery, Inc. today announced that the Company is scheduled to release financial results for the third quarter ended September 30, 2022 on Tuesday, November 1, 2022, after market close.
October 18, 2022
·
2 min read
Press Releases
Alzheon Announces Peer-Reviewed Scientific Publication of Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in APOE4/4 Homozygous Individuals with Early Alzheimer’s Disease
October 15, 2025
·
12 min read
1 of 72,193
Next
